Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Feb 21 424B4 Prospectus supplement with pricing info
- 5 Feb 21 EFFECT Notice of effectiveness
- 3 Feb 21 S-1/A IPO registration (amended)
-
1 Feb 21 S-1/A IPO registration (amended)
- 15 Jan 21 S-1 IPO registration
TERN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated November 10, 2020 (except for the fifth paragraph of Note 1, as to which the date is February 1, 2021), in Amendment 1 of the Registration Statement (Form S-1 No 333-252180) and related Prospectus of Terns Pharmaceuticals, Inc for the registration of shares of its common stock.
/s/ Ernst & Young LLP
San Jose, California
February 1, 2021